Have you seen our new ‘How I treat…’ features? Become a member (it’s free!) and discover the latest advice from fellow clinicians here >>>

In Focus

In Focus: recent therapies for thyroid cancer

In our latest In Focus, Kate Newbold (Royal Marsden Hospital in London, UK) discusses treatment options for thyroid cancer and their limitations. Newbold also explores how we can ...

In Focus: recent therapies in renal cell carcinoma

In our latest In Focus, Prof Brian Rini (Vanderbilt-Ingram Cancer Center, TN, USA) discusses the treatment landscape for people living with renal cell carcinoma (RCC), as well as the ...

Publication In Focus: GioTag

The GioTag study investigated TKI sequencing in real-world patients with EGFR mutation-positive non-small-cell lung cancer (NSCLC) who develop T790M. The final data confirmed those of ...

Publication In Focus: INSIGHT MM

With the introduction of new drugs with different mechanisms of action, multiple myeloma (MM) patients’ outcomes have improved. However, the efficacy seen in clinical trials is often ...

In Focus: Comprehensive Genomic Profiling

Comprehensive Genomic Profiling (CGP) utilizes next-generation sequencing technology to enable simultaneous detection of multiple cancer biomarkers. Currently, many sequential tests ...

In Focus: coronavirus

Discover the latest oncology updates on the ongoing novel coronavirus outbreak. The COVID-19 outbreak has rapidly swept the world since first being reported in December 2019, leading to ...

In Focus: World Cancer Day

World Cancer Day is an initiative by the Union of International Cancer Control that aims to unite the cancer community and increase awareness of what we can do to prevent and fight ...

In Focus: CAR-T therapy

Traditionally, the foundation pillars of cancer treatment were surgery, radiotherapy and chemotherapy. However, with the advent of immuno-oncology – treatment modalities that utilize ...

In Focus: lung cancer

Over the past years, there have been great advancements in the field of lung cancer; with the success we have seen with immunotherapy drugs such as Keytruda for non-small cell lung ...

In Focus: hematologic malignancies

Numerous advancements have been made in treatment options for hematologic malignancies, with a big emphasis on precision medicine. As the field moves forwards with a stronger focus on ...

In Focus: colorectal cancer

The world’s third most common cancer, colorectal cancer is responsible for an estimated 694,000 annual deaths worldwide. The few last decades have brought great improvements in survival ...

In Focus: skin cancer

Over the past few years, advances in the treatment of skin cancers have improved both overall and progression free survival for patients. However, the sudden and increasing array of ...

In Focus: breast cancer

The roll out of more effective and affordable screening programes alongside advancements in treatment options have resulted in declining death rates over the last few decades. Despite ...

In Focus: cervical cancer

To mark Cervical Cancer Awareness Week we have collated our most-popular cervical cancer content. Highlights include breaking news, peer-reviewed research and opinion pieces from key ...